Abbott competitors

Abbott Competitors include Ra Medical Systems, Agilent Technologies, Bruker Corporation, Novo Nordisk, Johnson & Johnson and Amgen.

Add company...

Save Comparison Clear all	Abbott Abbott is a genomic disease management company that develops and markets clinical laboratory products.	Ra Medical Systems Ra Medical Systems develops, manufactures, and markets excimer lasers for use in the treatment of vascular and dermatological diseases.	Agilent Technologies Agilent Technologies provides application-focused solutions to the life sciences, diagnostics, and applied chemical markets.	Bruker Corporation Bruker Corporation manufactures and distributes scientific instruments, and analytical and diagnostic solutions internationally.	Novo Nordisk Novo Nordisk is a healthcare company and a world leader in diabetes care.	Johnson & Johnson Johnson & Johnson engages in the research and development, manufacture and sale of a range of products in the healthcare field.	Amgen Amgen engages in the development of human therapeutic products in supportive of cancer care, inflammation, nephrology and bone diseases.
Founding Date	Founding Date 1991	Founding Date 2002	Founding Date 1999	Founding Date 1960	Founding Date 1923	Founding Date 1886	Founding Date 1980
Type	Type Public	Type Public	Type Public	Type Public	Type Public	Type Public	Type Public
Tags	Tags Healthcare medical devices medical diagnostics pharma	Tags Healthcare Manufacturing & Industrial medical devices therapy	Tags Healthcare Technology biotech clinical research life sciences medical diagnostics medtech pharma	Tags Healthcare Manufacturing & Industrial life sciences medical devices medtech	Tags Healthcare clinical research diabetes pharma	Tags Healthcare Manufacturing & Industrial conglomerates consumer chemistry consumer goods health & beauty medical devices pharma	Tags Healthcare biotech drug development genetics oncology pharma
Locations	Locations Illinois City, US HQ Sao Paulo, BR Québec, CA Shanghai, CN Beijing, CN Wiesbaden, DE Tokyo, JP see more	Locations Carlsbad, US HQ	Locations Santa Clara, US HQ Victoria, AU Wien, AT Machelen, BE Leuven, BE Tamboré, BR Beijing, CN see more	Locations Billerica, US HQ Oran, DZ Kontich, BE Evere, BE Sofia, BG Burlington, CA Shanghai, CN see more	Locations Bagsvaerd, DK HQ Mississauga, CA Beijing, CN Mainz, DE Bangalore, IN Tokyo, JP Jersey, JE see more	Locations New Brunswick, US HQ Buenos Aires, AR Yerevan, AM Broadway, AU Dhaka, BD Minsk, BY see more	Locations Thousand Oaks, US HQ North Ryde, AU Sydney, AU Vienna, AT Brussels, BE São Paulo, BR Burnaby, CA see more
Employees	Employees 103,0004% increase	Employees 95	Employees 14,8002% increase	Employees 6,200	Employees 42,0761% increase	Employees 134,000	Employees 20,800
Valuation ($)	Valuation ($) 140.3 b	Valuation ($) 56.2 m	Valuation ($) 25.8 b	Valuation ($) 6.2 b	Valuation ($) 122.9 b	Valuation ($) 366.4 b	Valuation ($) 119 b
Twitter followers	Twitter followers 61.1 k	Twitter followers N/A	Twitter followers 22.8 k	Twitter followers 8.4 k	Twitter followers 25.8 k	Twitter followers 90.5 k	Twitter followers 65.4 k
Financial ⚠
Revenue (est.)	Revenue (est.) $30.6b (FY, 2018)	Revenue (est.) $5.9m (FY, 2017)	Revenue (est.) $4.9b (FY, 2018)	Revenue (est.) N/A	Revenue (est.) N/A	Revenue (est.) $81.6b (FY, 2018)	Revenue (est.) $23.7b (FY, 2018)
Cost of goods	Cost of goods $12.7b (FY, 2018)	Cost of goods $4.2m (FY, 2017)	Cost of goods $2.2b (FY, 2018)	Cost of goods N/A	Cost of goods N/A	Cost of goods $27.1b (FY, 2018)	Cost of goods $4.1b (FY, 2018)
Gross profit	Gross profit $17.9b (FY, 2018)	Gross profit $1.7m (FY, 2017)	Gross profit $2.7b (FY, 2018)	Gross profit N/A	Gross profit N/A	Gross profit $54.5b (FY, 2018)	Gross profit $19.6b (FY, 2018)
Net income	Net income $2.4b (FY, 2018)	Net income ($17.8m) (FY, 2017)	Net income $316m (FY, 2018)	Net income $181m (FY, 2018)	Net income N/A	Net income $15.3b (FY, 2018)	Net income $8.4b (FY, 2018)
Operating ⚠
Phase III Trials Products	Phase III Trials Products N/A	Phase III Trials Products N/A	Phase III Trials Products N/A	Phase III Trials Products N/A	Phase III Trials Products 3 (FY, 2016)	Phase III Trials Products 37 (Jan, 2019)	Phase III Trials Products N/A
Funding
Total funding raised	Total funding raised $ 6.8m	Total funding raised N/A	Total funding raised N/A	Total funding raised N/A	Total funding raised N/A	Total funding raised N/A	Total funding raised $ 175.5m